Steroid Dimer Articles for Controlled Drug Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug delivery systems face challenges such as drug degradation, burst release, low encapsulation efficiency, and unwanted side effects due to the use of carriers or matrices.

Innovation Solution

The development of steroid dimers and articles formed from these dimers, which can be processed into various shapes and forms, allowing for controlled release of the steroid through surface erosion without the need for controlled release excipients.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional carrier systems are used for drug delivery, then drug encapsulation is achieved, but burst release and unwanted side effects occur

Engineering Contradiction:
Improvecontrolled release performanceVSAvoidburst release and side effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The invention extracts and eliminates the carrier matrix component from traditional drug delivery systems. By using steroid dimers that self-assemble into fibrous structures without requiring external carriers or matrices, the system removes the source of burst release and unwanted side effects while maintaining controlled release functionality.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The steroid dimers self-assemble into fibrous structures autonomously without requiring external carriers, matrices, or complex formulation excipients. This self-organizing capability enables the system to achieve controlled release through its own structural properties, eliminating the need for traditional carrier systems that cause burst release.

Inventive Principle:
Principle #25Self-service

2Reliability

If controlled release excipients are used in drug delivery articles, then release control is achieved, but device complexity and manufacturing complexity increase

Engineering Contradiction:
Improvesustained release capabilityVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention removes controlled release excipients, polymers, and matrices from the formulation. The steroid dimers themselves form the structural basis for controlled release through self-assembly into fibrous articles, eliminating the need for additional complexity-introducing components.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The formulation consists essentially of only the steroid dimer compound, creating a homogeneous system without multiple excipients, polymers, or matrices. This simplicity in composition directly reduces device and formulation complexity while maintaining sustained release capability through the uniform self-assembled fibrous structure.

Inventive Principle:
Principle #33Homogeneity

3Quantity of substance

If traditional drug delivery systems are used, then drug delivery is achieved, but drug degradation occurs

Engineering Contradiction:
Improvedrug loadingVSAvoiddrug stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The steroid dimers self-assemble into stable fibrous structures that protect the drug payload from degradation. The self-formed fibrous matrix provides a stable environment for drug incorporation and release, eliminating the need for external protective carriers that may themselves degrade or cause drug instability.

Inventive Principle:
Principle #25Self-service

4Quantity of substance

If carrier systems with matrices are used, then drug encapsulation efficiency is improved, but encapsulation efficiency actually decreases due to burst release

Engineering Contradiction:
Improvedrug loadingVSAvoidencapsulation efficiency
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention eliminates the carrier matrix that causes burst release. By using steroid dimers that self-assemble directly into fibrous structures, the system achieves true encapsulation efficiency without the detrimental effects of matrix-based carriers that lead to premature drug release.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables a sustained and uniform release of steroids over an extended period, minimizing burst release and side effects associated with traditional carrier systems, while maintaining high drug loading and local effectiveness.

Implementation Method 1

In some embodiments, the compound, D1, or D2 are released from the article through surface erosion.

Methodology Applied
Scientific EffectSurface erosion: Erosion

Data Source

PatentUS20250049719A1Dexamethasone prodrug compositions and uses thereof
Publication Date: 2025.02.13 RIPPLE THERAPEUTICS CORP
  • US20250049719A1 patent drawing
  • US20250049719A1 patent drawing
  • US20250049719A1 patent drawing

AI summary

The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.